Healthcare Triangle (HCTI) EBITDA (2020 - 2026)

Healthcare Triangle has disclosed EBITDA across 7 years of filings, most recently posting -$6.4 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$6.4 million, down 274.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.1 million (down 7.78% YoY), and the FY2025 annual result was -$9.5 million, up 29.39% from the prior year.
• EBITDA came in at -$6.4 million for Q1 2026 at Healthcare Triangle, down from -$4.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$1.2 million in Q3 2024 to a low of -$10.6 million in Q4 2022.
• The 5-year median for EBITDA is -$1.7 million (2024), against an average of -$3.1 million.
• Across the five-year window, EBITDA soared 87.48% in 2023 and sank 559.38% in 2024, its largest moves.
• Healthcare Triangle's EBITDA stood at -$10.6 million in 2022, then jumped by 87.48% to -$1.3 million in 2023, then tumbled by 559.38% to -$8.8 million in 2024, then jumped by 48.79% to -$4.5 million in 2025, then slumped by 41.49% to -$6.4 million in 2026.
• The last three EBITDA figures came in at -$6.4 million (Q1 2026), -$4.5 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.